Literature DB >> 27749141

Comparison of Haloperidol Alone and in Combination with Midazolam for the Treatment of Acute Agitation in an Inpatient Palliative Care Service.

José António Ferraz Gonçalves, Ana Almeida, Isabel Costa, Paula Silva, Rui Carneiro.   

Abstract

Agitation is a very distressing problem that must be controlled as quickly as possible, but using a safe method. The authors conducted a comparison of two protocols: a combination of haloperidol and midazolam and haloperidol alone. The combination drug protocol controlled 101 out of 121 (84%) episodes of agitation with only the first dose, whereas the haloperidol alone protocol controlled 47 out of 74 (64%) episodes. This difference is statistically significant (P =.002), with a post hoc analyzed power of 0.88. The median time from the first dose to the control of agitation was 15 minutes (range: 5-210) with the combination and 60 minutes (range: 10-430) with the other protocol, P <.001. There were no complications other than some transient somnolence, mainly with the combination protocol. The authors conclude that the combination of haloperidol and midazolam is effective and safe for the control of agitation in palliative care and it is more effective than haloperidol alone. Therefore, the combination should be adopted as the preferred protocol. It would be helpful if the usefulness of this protocol is confirmed by others.

Entities:  

Keywords:  agitation; haloperidol; hyperactive delirium; midazolam; palliative care; place-randomized trial

Mesh:

Substances:

Year:  2016        PMID: 27749141     DOI: 10.1080/15360288.2016.1231733

Source DB:  PubMed          Journal:  J Pain Palliat Care Pharmacother        ISSN: 1536-0288


  6 in total

1.  Drug therapy for delirium in terminally ill adults.

Authors:  Anne M Finucane; Louise Jones; Baptiste Leurent; Elizabeth L Sampson; Patrick Stone; Adrian Tookman; Bridget Candy
Journal:  Cochrane Database Syst Rev       Date:  2020-01-21

2.  Benzodiazepines for treatment of patients with delirium excluding those who are cared for in an intensive care unit.

Authors:  Yan Li; Jun Ma; Yinghui Jin; Nan Li; Rui Zheng; Wei Mu; Jiaying Wang; Jin Hua Si; Jing Chen; Hong Cai Shang
Journal:  Cochrane Database Syst Rev       Date:  2020-02-28

Review 3.  Clinical Assessment and Management of Delirium in the Palliative Care Setting.

Authors:  Shirley Harvey Bush; Sallyanne Tierney; Peter Gerard Lawlor
Journal:  Drugs       Date:  2017-10       Impact factor: 9.546

4.  Investigation of the synergistic effects of haloperidol combined with Calculus Bovis Sativus in treating MK-801-induced schizophrenia in rats.

Authors:  Kai Lei; Guo-Fang He; Cheng-Liang Zhang; Ya-Nan Liu; Juan Li; Guang-Zhao He; Xi-Ping Li; Xiu-Hua Ren; Dong Liu
Journal:  Exp Anim       Date:  2017-12-08

5.  Identification and evaluation of observational measures for the assessment and/or monitoring of level of consciousness in adult palliative care patients: A systematic review for I-CAN-CARE.

Authors:  Anna-Maria Krooupa; Bella Vivat; Stephen McKeever; Elena Marcus; Joseph Sawyer; Paddy Stone
Journal:  Palliat Med       Date:  2019-08-22       Impact factor: 5.713

6.  Association among rescue neuroleptic use, agitation, and perceived comfort: secondary analysis of a randomized clinical trial on agitated delirium.

Authors:  Michael Tang; Minxing Chen; Eduardo Bruera; David Hui
Journal:  Support Care Cancer       Date:  2021-06-29       Impact factor: 3.603

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.